Federal Register Notice: FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee will meet 8/27, from 8 a.m. to 5:30 p.m. at Food and Drug Administration, CDER Advisory Committee Conference Room, 5630 Fishers Lane, Rm. 1066, Rockville, MD. The committee will discuss an Eyetech Pharmaceuticals’ NDA for pegaptanib sodium injection (proposed tradename, Macugen) indicated for the treatment of exudative (wet) age-related macular degeneration. Contact Kimberly Littleton Topper, (301) 827-7001. To view this notice, click here.
